BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

816 related articles for article (PubMed ID: 30384370)

  • 1. Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease.
    Chinnadurai R; Chrysochou C; Kalra PA
    Nephron; 2019; 141(1):24-30. PubMed ID: 30384370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R; Ritchie J; Green D; Kalra PA
    Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes.
    Li M; Zhao Z; Qin G; Chen L; Lu J; Huo Y; Chen L; Zeng T; Xu M; Chen Y; Wang T; Wang S; Xu Y; Shi L; Tang X; Su Q; Yu X; Yan L; Wan Q; Chen G; Gao Z; Wang G; Shen F; Luo Z; Zhang Y; Liu C; Wang Y; Hu R; Ye Z; Wu S; Deng H; Yang T; Li Q; Qin Y; Mu Y; Zhao J; Ning G; Bi Y; Xu Y; Wang W
    Metabolism; 2021 Nov; 124():154874. PubMed ID: 34517014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study.
    Sinn DH; Kang D; Jang HR; Gu S; Cho SJ; Paik SW; Ryu S; Chang Y; Lazo M; Guallar E; Cho J; Gwak GY
    J Hepatol; 2017 Dec; 67(6):1274-1280. PubMed ID: 28870674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of estimated glomerular filtration rate and urine albumin-to-creatinine ratio with incidence of cardiovascular diseases and mortality in chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study.
    Fung CS; Wan EY; Chan AK; Lam CL
    BMC Nephrol; 2017 Feb; 18(1):47. PubMed ID: 28152985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
    Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
    Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased mortality in non-alcoholic fatty liver disease with chronic kidney disease is explained by metabolic comorbidities.
    Önnerhag K; Dreja K; Nilsson PM; Lindgren S
    Clin Res Hepatol Gastroenterol; 2019 Oct; 43(5):542-550. PubMed ID: 30827925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up.
    Fracanzani AL; Tiraboschi S; Pisano G; Consonni D; Baragetti A; Bertelli C; Norata D; Valenti L; Grigore L; Porzio M; Catapano A; Fargion S
    Atherosclerosis; 2016 Mar; 246():208-13. PubMed ID: 26803429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of non-alcoholic fatty liver disease in the evolution of renal function in patients with diabetes mellitus.
    Aubert L; Sandino J; Gutiérrez-Solís E; García-Martín F; Segura J; Porrini E; Morales E
    Nephrol Dial Transplant; 2022 May; 37(6):1125-1131. PubMed ID: 33983444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Non-Alcoholic Fatty Liver Disease and Diabetes-Related Microvascular Complications: A Retrospective Cross-Sectional Study of Hospitalized Patients.
    Wen X; Zhou X; Chen D; Cheng J; Ji L
    Endocr Pract; 2022 Mar; 28(3):304-309. PubMed ID: 33601024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prognosis of Patients With Type 2 Diabetes and Nonalbuminuric Diabetic Kidney Disease Is Not Always Poor: Implication of the Effects of Coexisting Macrovascular Complications (JDDM 54).
    Yokoyama H; Araki SI; Kawai K; Yamazaki K; Shirabe SI; Sugimoto H; Minami M; Miyazawa I; Maegawa H;
    Diabetes Care; 2020 May; 43(5):1102-1110. PubMed ID: 32144168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and its association with cardiovascular disease.
    Vanjiappan S; Hamide A; Ananthakrishnan R; Periyasamy SG; Mehalingam V
    Diabetes Metab Syndr; 2018 Jul; 12(4):479-482. PubMed ID: 29402657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes.
    Mantovani A; Mingolla L; Rigolon R; Pichiri I; Cavalieri V; Zoppini G; Lippi G; Bonora E; Targher G
    Int J Cardiol; 2016 Dec; 225():387-391. PubMed ID: 27768965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study.
    Chen S; Chen L; Jiang H
    Ren Fail; 2022 Dec; 44(1):1309-1318. PubMed ID: 35938702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Diabetic Retinopathy and Diabetic Kidney Disease With All-Cause and Cardiovascular Mortality in a Multiethnic Asian Population.
    Sabanayagam C; Chee ML; Banu R; Cheng CY; Lim SC; Tai ES; Coffman T; Wong TY
    JAMA Netw Open; 2019 Mar; 2(3):e191540. PubMed ID: 30924904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Diabetes Mellitus and All-Cause and Cardiovascular Mortality Among Individuals With Ultrasound-Defined Non-Alcoholic Fatty Liver Disease.
    Wu W; Xiang J; Chen X
    Front Endocrinol (Lausanne); 2021; 12():773342. PubMed ID: 34992579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in the impact of nonalcoholic fatty liver disease on cardiovascular risk factors.
    Du T; Sun X; Yuan G; Zhou X; Lu H; Lin X; Yu X
    Nutr Metab Cardiovasc Dis; 2017 Jan; 27(1):63-69. PubMed ID: 27956025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease.
    Henson JB; Simon TG; Kaplan A; Osganian S; Masia R; Corey KE
    Aliment Pharmacol Ther; 2020 Apr; 51(7):728-736. PubMed ID: 32043602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between atherosclerotic cardiovascular diseases risk and renal outcome in patients with type 2 diabetes mellitus.
    Ren H; Zhao L; Zou Y; Wang Y; Zhang J; Wu Y; Zhang R; Wang T; Wang J; Zhu Y; Guo R; Xu H; Li L; Cooper ME; Liu F
    Ren Fail; 2021 Dec; 43(1):477-487. PubMed ID: 33685340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China.
    Liang Y; Chen H; Liu Y; Hou X; Wei L; Bao Y; Yang C; Zong G; Wu J; Jia W
    J Clin Endocrinol Metab; 2022 Jan; 107(1):88-97. PubMed ID: 34508601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.